800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension (REBUILD)

view all Clinical Trials

Overview

A randomized, double-blind, placebo-controlled dose escalation and verification study to assess the safety and efficacy of pulsed inhaled nitric oxide (iNO) versus placebo in subjects at risk for pulmonary hypertension associated with pulmonary fibrosis on long term oxygen therapy. (REBUILD)

Clinical Trial Information

Protocol

TIRB: 25059 WIRB: 20172181

Phase

2/3

Condition(s)

Pulmonary Fibrosis (Including IPF), Pulmonary Hypertension (PH)

Investigator

Parth Rali, MD

Coordinator

Dee Fehrle

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (REBUILD)